These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 24319172)

  • 21. Six cases of rare gene amplifications and multiple copy of fusion gene in childhood acute lymphoblastic leukemia.
    Haltrich I; Csóka M; Kovács G; Török D; Alpár D; Ottoffy G; Fekete G
    Pathol Oncol Res; 2013 Jan; 19(1):123-8. PubMed ID: 22528566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion.
    Oya S; Morishige S; Ozawa H; Sasaki K; Semba Y; Yamasaki Y; Nakamura T; Aoyama K; Seki R; Mouri F; Osaki K; Miyamoto T; Maeda T; Nagafuji K
    Int J Hematol; 2021 Feb; 113(2):285-289. PubMed ID: 32951102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency and clinical impact of ETV6/RUNX1, AF4-MLL, and BCR/ABL fusion genes on features of acute lymphoblastic leukemia at presentation.
    Ajuba IC; Madu AJ; Okocha C; Ibegbulam OG; Okpala I; Nna OE
    Niger J Clin Pract; 2016; 19(2):237-41. PubMed ID: 26856288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostically significant fusion oncogenes in Pakistani patients with adult acute lymphoblastic leukemia and their association with disease biology and outcome.
    Sabir N; Iqbal Z; Aleem A; Awan T; Naeem T; Asad S; Tahir AH; Absar M; Hasanato RM; Basit S; Chishti MA; Faiyaz Ul-Haque M; Khalid AM; Sabar MF; Rasool M; Karim S; Khan M; Samreen B; Akram AM; Siddiqi MH; Shahzadi S; Shahbaz S; Ali AS; Mahmood A; Akram M; Saeed T; Saleem A; Mohsin D; Shah IH; Khalid M; Asif M; Iqbal M; Akhtar T
    Asian Pac J Cancer Prev; 2012; 13(7):3349-55. PubMed ID: 22994759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of the miRNA expression by TEL/AML1, BCR/ABL, MLL/AF4 and TCF3/PBX1 oncoproteins in acute lymphoblastic leukemia (Review).
    Organista-Nava J; Gómez-Gómez Y; Illades-Aguiar B; Leyva-Vázquez MA
    Oncol Rep; 2016 Sep; 36(3):1226-32. PubMed ID: 27431573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fishing for ETV6/RUNX1 fusion and MLL gene rearrangements and their additional abnormalities in childhood acute lymphoblastic leukemia patients of Kashmir.
    Mohiuddin Malla T; Amin Shah Z; Hussain Bhat A; Ahmad Malik M; Anjum Baba R; Rasool R; Rasool J; Ashaq S; Haq F
    Gene; 2023 Mar; 856():147128. PubMed ID: 36565795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia.
    Al-Shehhi H; Konn ZJ; Schwab CJ; Erhorn A; Barber KE; Wright SL; Gabriel AS; Harrison CJ; Moorman AV
    Genes Chromosomes Cancer; 2013 Feb; 52(2):202-13. PubMed ID: 23077088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study.
    Moorman AV; Barretta E; Butler ER; Ward EJ; Twentyman K; Kirkwood AA; Enshaei A; Schwab C; Creasey T; Leongamornlert D; Papaemmanuil E; Patrick P; Clifton-Hadley L; Patel B; Menne T; McMillan AK; Harrison CJ; Rowntree CJ; Marks DI; Fielding AK
    Leukemia; 2022 Mar; 36(3):625-636. PubMed ID: 34657128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia.
    Geng H; Brennan S; Milne TA; Chen WY; Li Y; Hurtz C; Kweon SM; Zickl L; Shojaee S; Neuberg D; Huang C; Biswas D; Xin Y; Racevskis J; Ketterling RP; Luger SM; Lazarus H; Tallman MS; Rowe JM; Litzow MR; Guzman ML; Allis CD; Roeder RG; Müschen M; Paietta E; Elemento O; Melnick AM
    Cancer Discov; 2012 Nov; 2(11):1004-23. PubMed ID: 23107779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.
    Roberts KG; Morin RD; Zhang J; Hirst M; Zhao Y; Su X; Chen SC; Payne-Turner D; Churchman ML; Harvey RC; Chen X; Kasap C; Yan C; Becksfort J; Finney RP; Teachey DT; Maude SL; Tse K; Moore R; Jones S; Mungall K; Birol I; Edmonson MN; Hu Y; Buetow KE; Chen IM; Carroll WL; Wei L; Ma J; Kleppe M; Levine RL; Garcia-Manero G; Larsen E; Shah NP; Devidas M; Reaman G; Smith M; Paugh SW; Evans WE; Grupp SA; Jeha S; Pui CH; Gerhard DS; Downing JR; Willman CL; Loh M; Hunger SP; Marra MA; Mullighan CG
    Cancer Cell; 2012 Aug; 22(2):153-66. PubMed ID: 22897847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic abnormalities and drug resistance in acute lymphoblastic leukemia.
    Pui CH; Evans WE
    Adv Exp Med Biol; 1999; 457():383-9. PubMed ID: 10500813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
    Davis K; Sheikh T; Aggarwal N
    Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia.
    Xie J; Wang Q; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S
    Cancer Genet; 2014 May; 207(5):226-30. PubMed ID: 24998463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteopontin-c is overexpressed in KMT2A-AFF1 positive pediatric B-cell lymphoblastic leukemia when compared to those with ETV6-RUNX1".
    da Fonseca Bastos ACS; da Silva Rezende AC; Ferreira LB; Blunck CB; Pombo-de-Oliveira MS; Emerenciano M; Gimba ERP
    Leuk Res; 2020 Apr; 91():106316. PubMed ID: 32114371
    [No Abstract]   [Full Text] [Related]  

  • 35. Frequency of the ETV6-RUNX1, BCR-ABL1, TCF3-PBX1, and MLL-AFF1 fusion genes in Guatemalan pediatric acute lymphoblastic leukemia patients and their ethnic associations.
    Carranza C; Granados L; Morales O; Jo W; Villagran S; Tinti D; Villegas M; Antillón F; Torselli S; Silva G
    Cancer Genet; 2013 Jun; 206(6):227-32. PubMed ID: 23859904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coexistence of ETV6/RUNX1 and MLL aberrations in B-cell precursor acute lymphoblastic leukemia discloses a small subclass of BCP-ALL.
    Amare Kadam PS; Raje GC; Pais AP; Banavali S
    Cancer Genet Cytogenet; 2008 Apr; 182(1):27-32. PubMed ID: 18328947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party.
    Iacobucci I; Lonetti A; Paoloni F; Papayannidis C; Ferrari A; Storlazzi CT; Vignetti M; Cilloni D; Messa F; Guadagnuolo V; Paolini S; Elia L; Messina M; Vitale A; Meloni G; Soverini S; Pane F; Baccarani M; Foà R; Martinelli G
    Haematologica; 2010 Oct; 95(10):1683-90. PubMed ID: 20534699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-Wide Single-Nucleotide Polymorphism Array Analysis Improves Prognostication of Acute Lymphoblastic Leukemia/Lymphoma.
    Wang Y; Miller S; Roulston D; Bixby D; Shao L
    J Mol Diagn; 2016 Jul; 18(4):595-603. PubMed ID: 27161658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates.
    Boer JM; Koenders JE; van der Holt B; Exalto C; Sanders MA; Cornelissen JJ; Valk PJ; den Boer ML; Rijneveld AW
    Haematologica; 2015 Jul; 100(7):e261-4. PubMed ID: 25769542
    [No Abstract]   [Full Text] [Related]  

  • 40. Advances in B-cell Precursor Acute Lymphoblastic Leukemia Genomics.
    Schwab C; Harrison CJ
    Hemasphere; 2018 Aug; 2(4):e53. PubMed ID: 31723781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.